News: David Penson

Study Reveals Racial Disparities in Prostate Cancer Care

Thursday, August 23rd, 2012

A study led by investigators from Vanderbilt-Ingram Cancer Center (VICC), Nashville, Tenn., finds that black men with prostate cancer receive lower quality surgical care than white men. The racial differences persist even when controlling for factors such as the year of surgery, age, comorbidities and insurance status. Daniel Barocas, M.D., MPH, assistant professor of Urologic […]

Penson Appointed to AHRQ Advisory Council

Friday, March 23rd, 2012

The Agency for Healthcare Research and Quality (AHRQ) of the U.S. Department of Health & Human Services recently appointed Vanderbilt’s David Penson, M.D., MPH, to the National Advisory Council for Healthcare Research and Quality. Penson, professor of Urologic Surgery and director of the Center for Surgical Quality and Outcomes, joins a 21-member panel comprised of […]

Decision Tree

Wednesday, June 22nd, 2011

Kort Nygard opted to wait until his prostate cancer needed treatment. Then he decided to have open surgery. Jim Davidson chose radiation therapy, the external beam type. Sam Dick selected robotic surgery. Three different patients with prostate cancer, three different treatment choices. The decision that faces a man diagnosed with localized prostate cancer is daunting. […]

Taming the Tiger

Wednesday, June 22nd, 2011

About a third of patients who are treated for localized prostate cancer will have a recurrence, says David Penson, M.D., MPH. A small percentage of patients already have metastatic prostate cancer – cancer that has spread beyond the prostate gland – when they are first diagnosed. “Metastatic prostate cancer is a tiger that’s out of […]